Farber...very good comparison. BUT, U left 1 very important idea out of the analysis: Lovaza a $900 mil drug that is inferior to Vascepa. And, the Vascepa statin combo results will confirm that it is a real winner. It reduces the side effects of the statin, AND allows the script mgs of the statin to be reduced. ALL GOOD !
About 70 percent of the nation's supplement companies have run afoul of the U.S. Food and Drug Administration's manufacturing regulations over the past five years, according to a top agency official.
Consumers are put at risk by poorly measured ingredients, uncleaned manufacturing equipment, pesticides in herbal products, supplements contaminated with illegal prescription medications -- even bacteria in pediatric vitamins, recall notices and agency inspection records have shown.
"We're seeing some real problems out there," said Dr. Daniel Fabricant, who heads the FDA's division of Dietary Supplement Programs, referring to manufacturing issues affecting a large number of dietary supplement companies.